PDGFRB and atherosclerosis: Our findings thus suggest that abnormal activation of PDGFRβ signaling, which has so far not been reported in MFS, is the major mediator of the increased atherosclerosis in the smLRP− mice, and that increased PDGFRβ activity is brought about by two independent and synergistic mechanisms.